Chinese Liver Cancer Clinical Survey
关键词
抽象
描述
Primary liver cancer (PLC) is one of the most common malignant tumors of digestive system and also a serious threat to the health and safety of Chinese people, and has caused serious economic burden to the country. Research purposes: To understand the clinical characteristics of patients with primary liver cancer (PLC) in China; To investigate the etiology and pathogenesis of PLC in China; To understand the current status of clinical treatment of PLC in China, and to analyze the gaps among these conditions and domestic treatment guidelines, industry consensus, the international treatment guidelines; To understand the different treatment options and its clinical outcomes, and to explore the best treatment options; To explore the best clinical pathway of PLC multidisciplinary consultation; To provide the basis for the development of clinical guidelines for PLC in China.
日期
| 最后验证: | 04/30/2017 |
| 首次提交: | 05/18/2017 |
| 提交的预估入学人数: | 05/18/2017 |
| 首次发布: | 05/21/2017 |
| 上次提交的更新: | 05/18/2017 |
| 最近更新发布: | 05/21/2017 |
| 实际学习开始日期: | 11/27/2016 |
| 预计主要完成日期: | 08/30/2017 |
| 预计完成日期: | 08/30/2017 |
状况或疾病
相
资格标准
| 有资格学习的性别 | All |
| 取样方式 | Non-Probability Sample |
| 接受健康志愿者 | 是 |
| 标准 | Inclusion Criteria: - Diagnosis of PLC after January 1,2012; - First treatment and efficacy evaluation. Exclusion Criteria: - Complicated with another primary malignant tumor and secondary liver cancer. |
结果
主要结果指标
1. Overall survival [5 years]
